Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

Go back to Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis
(NASDAQ: MCRB) Delayed: 5.23 -0.05 (0.95%)
Previous Close $5.28    52 Week High $44.51 
Open $5.21    52 Week Low $8.05 
Day High $5.36    P/E N/A 
Day Low $5.11    EPS $0.00 
Volume 29,817